Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Garay

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Molecular Oncology|March 27, 2012
Omics and therapy - a basis for precision medicineJoseph P Garay, Joe W Gray
American Journal of Cancer Research|August 4, 2012
Androgen receptor as a targeted therapy for breast cancerJoseph P Garay, Ben H Park
FEBS Open Bio|March 5, 2021
CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cellsShen Li, Joseph P Garay, Colby A Tubbs, et al.
Genome Biology|August 20, 2021
MultiK: an automated tool to determine optimal cluster numbers in single-cell RNA sequencing dataSiyao Liu, Aatish Thennavan, Joseph P Garay, et al.
Nature Protocols|November 17, 2007
A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targetingHiroyuki Konishi, Josh Lauring, Joseph P Garay, et al.
Blood|October 19, 2007
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicityJosh Lauring, Abde M Abukhdeir, Hiroyuki Konishi, et al.
Cancer Research|September 19, 2007
Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformationHiroyuki Konishi, Bedri Karakas, Abde M Abukhdeir, et al.
Breast Cancer Research : BCR|August 4, 2021
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CAJoseph P Garay, Rebecca Smith, Kaylyn Devlin, et al.
Oncotarget|December 26, 2015
TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancerHong Yuen Wong, Grace M Wang, Sarah Croessmann, et al.
Cancer Biology & Therapy|December 3, 2010
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cellsMichaela J Higgins, Julia A Beaver, Hong Yuen Wong, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Molecular Oncology|March 27, 2012
Omics and therapy - a basis for precision medicineJoseph P Garay, Joe W Gray
American Journal of Cancer Research|August 4, 2012
Androgen receptor as a targeted therapy for breast cancerJoseph P Garay, Ben H Park
FEBS Open Bio|March 5, 2021
CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cellsShen Li, Joseph P Garay, Colby A Tubbs, et al.
Genome Biology|August 20, 2021
MultiK: an automated tool to determine optimal cluster numbers in single-cell RNA sequencing dataSiyao Liu, Aatish Thennavan, Joseph P Garay, et al.
Nature Protocols|November 17, 2007
A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targetingHiroyuki Konishi, Josh Lauring, Joseph P Garay, et al.
Blood|October 19, 2007
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicityJosh Lauring, Abde M Abukhdeir, Hiroyuki Konishi, et al.
Cancer Research|September 19, 2007
Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformationHiroyuki Konishi, Bedri Karakas, Abde M Abukhdeir, et al.
Breast Cancer Research : BCR|August 4, 2021
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CAJoseph P Garay, Rebecca Smith, Kaylyn Devlin, et al.
Oncotarget|December 26, 2015
TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancerHong Yuen Wong, Grace M Wang, Sarah Croessmann, et al.
Cancer Biology & Therapy|December 3, 2010
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cellsMichaela J Higgins, Julia A Beaver, Hong Yuen Wong, et al.
Pageof 3